AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,167,000 | -83.2% | 111,751 | -82.7% | 0.00% | -86.2% |
| Q2 2022 | $6,956,000 | +13.0% | 647,700 | -0.4% | 0.03% | +31.8% |
| Q1 2022 | $6,156,000 | -33.4% | 650,000 | -18.8% | 0.02% | -38.9% |
| Q4 2021 | $9,240,000 | -8.3% | 800,000 | -24.2% | 0.04% | -10.0% |
| Q3 2021 | $10,076,000 | +111.5% | 1,055,000 | +113.5% | 0.04% | +81.8% |
| Q2 2021 | $4,764,000 | +0.5% | 494,178 | +3.0% | 0.02% | -4.3% |
| Q1 2021 | $4,739,000 | – | 479,678 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |